The U.S. Food and Drug Administration (FDA) has announced a multi-year, comprehensive plan for tobacco and nicotine regulation that aims to reduce tobacco-related disease and death. This plan includes two major actions: reducing the nicotine content in cigarettes to non-addictive levels and encouraging the development of safer alternatives to cigarettes by postponing product application deadlines for e-cigarettes and vaping products.
These actions “ensure that the FDA has the proper scientific and regulatory foundation to efficiently and effectively implement the Family Smoking Prevention and Tobacco Control Act,” according to a press release from the agency.
The FDA also will seek public input on other plans to regulate tobacco and nicotine products, including studying the role that flavored tobacco products play in attracting youth. Additionally, the agency will examine efforts to increase access to and use of FDA-approved medicinal nicotine products.
FDA Commissioner Scott Gottlieb said the goal of these actions is to dissuade smokers from traditional cigarettes, help smokers quit, and prevent a new generation of smokers from developing. “Unless we change course, 5.6 million young people alive today will die prematurely later in life from tobacco use. Envisioning a world where cigarettes would no longer create or sustain addiction, and where adults who still need or want nicotine could get it from alternative and less harmful sources, needs to be the cornerstone of our efforts – and we believe it’s vital that we pursue this common ground,” he said in a press release from the agency.
Source: FDA press release, July 28, 2017.